Literature DB >> 4983662

Characterization of human anti-glomerular basement membrane antibodies eluted from glomerulonephritic kidneys.

J J McPhaul, F J Dixon.   

Abstract

Eluates from glomerulonephritic kidneys of nine patients with anti-glomerular basement membrane (anti-GBM)-mediated nephritis were studied to define their antigenic specificity and content of kidney-fixing antibodies. Five of these patients had Goodpasture's syndrome with pulmonary and renal involvement clinically; four patients did not. All had in vivo fixation of IgG in the characteristic linear pattern by direct immunofluorescence, and eluted IgG fixed to normal human kidney sections. Eluates from kidneys of patients with Goodpasture's syndrome fixed more frequently to homologous nonglomerular renal and extrarenal antigenic sites and to heterologous GBM than did non-Goodpasture eluates over a hundredfold range of antibody concentrations; both could be blocked by prior absorption with soluble GBM antigens. By radial immunodiffusion and precipitation tests the content of IgG in the eluates was measured to range from 2 to 20% of the total protein eluted. By paired label isotopic fixation studies with some of the eluates the per cent of IgG that was kidney fixing ranged from 0.6 to 23.4%. Although the in vivo fixation studies with radiolabeled eluates failed to indicate significant fixation to monkey lung, the observations define quantitative as well as qualitative differences between anti-GBM antibody populations mediating the Good-pasture syndrome compared to those causing glomerulonephritis without lung involvement.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4983662      PMCID: PMC322473          DOI: 10.1172/JCI106240

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  A DIALYSIS TECHNIQUE FOR PREPARING FLUORESCENT ANTIBODY.

Authors:  H F CLARK; C C SHEPARD
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

3.  A specific soluble substance involved in nephrotoxic nephritis.

Authors:  L R COLE; W J CROMARTIE; D W WATSON
Journal:  Proc Soc Exp Biol Med       Date:  1951-07

4.  The zone of localization of antibodies. IX. The properties of anti-rat-lung serum.

Authors:  H N EISEN; B SHERMAN; D PRESSMAN
Journal:  J Immunol       Date:  1950-11       Impact factor: 5.422

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Studies on the renal glomerular basement membrane. Nature of the carbohydrate units and their attachment to the peptide portion.

Authors:  R G Spiro
Journal:  J Biol Chem       Date:  1967-04-25       Impact factor: 5.157

7.  Autoimmune glomerulonephritis induced in sheep by injections of human lung and Freund's adjuvant.

Authors:  R W Steblay; U Rudofsky
Journal:  Science       Date:  1968-04-12       Impact factor: 47.728

8.  Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis.

Authors:  C Krishnan; M H Kaplan
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  32 in total

1.  Antibodies against C1q in anti-glomerular basement membrane nephritis.

Authors:  I E Coremans; M R Daha; E A van der Voort; Y Muizert; C Halma; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

2.  The gene corresponding to the putative Goodpasture antigen is present in Alport's syndrome.

Authors:  J A Savige
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

3.  Quantitative elution studies in experimental immune complex and nephrotoxic nephritis.

Authors:  S R Bartolotti
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

4.  Identification of Goodpasture antigens in human alveolar basement membrane.

Authors:  K Yoshioka; T Iseki; M Okada; Y Morimoto; N Eryu; S Maki
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

5.  Autoimmune glomerulotubular nephropathy in mice.

Authors:  W K Bolton; F R Benton; B C Sturgill
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

6.  The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit.

Authors:  P Trevillian; J S Cameron
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

7.  Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics.

Authors:  J J McPhaul; J D Mullins
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

8.  Induction of autoimmunity to antigens of the glomerular basement membrane in inbred Brown-Norway rats.

Authors:  M Stuffers-Heiman; E Günther; L A van Es
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

Review 9.  Spontaneous glomerular sclerosis in aging Sprague-Dawley rats. I. Lesions associated with mesangial IgM deposits.

Authors:  W K Bolton; F R Benton; J G Maclay; B C Sturgill
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

10.  Cellular and circulating immunity to diabetic basement membrane, a negative finding.

Authors:  A De Bats; J R Park; E L Rhodes
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.